全文获取类型
收费全文 | 153111篇 |
免费 | 10057篇 |
国内免费 | 771篇 |
专业分类
耳鼻咽喉 | 1406篇 |
儿科学 | 3898篇 |
妇产科学 | 2762篇 |
基础医学 | 20567篇 |
口腔科学 | 3455篇 |
临床医学 | 14722篇 |
内科学 | 32948篇 |
皮肤病学 | 2876篇 |
神经病学 | 14804篇 |
特种医学 | 6129篇 |
外国民族医学 | 6篇 |
外科学 | 23002篇 |
综合类 | 1904篇 |
现状与发展 | 2篇 |
一般理论 | 139篇 |
预防医学 | 11049篇 |
眼科学 | 3197篇 |
药学 | 10489篇 |
2篇 | |
中国医学 | 245篇 |
肿瘤学 | 10337篇 |
出版年
2023年 | 818篇 |
2022年 | 1238篇 |
2021年 | 2828篇 |
2020年 | 1956篇 |
2019年 | 2816篇 |
2018年 | 3427篇 |
2017年 | 2663篇 |
2016年 | 3045篇 |
2015年 | 3512篇 |
2014年 | 5031篇 |
2013年 | 6801篇 |
2012年 | 10518篇 |
2011年 | 11137篇 |
2010年 | 6349篇 |
2009年 | 6043篇 |
2008年 | 10196篇 |
2007年 | 10878篇 |
2006年 | 10350篇 |
2005年 | 10596篇 |
2004年 | 10001篇 |
2003年 | 9486篇 |
2002年 | 8906篇 |
2001年 | 1483篇 |
2000年 | 1112篇 |
1999年 | 1594篇 |
1998年 | 2106篇 |
1997年 | 1646篇 |
1996年 | 1421篇 |
1995年 | 1289篇 |
1994年 | 1140篇 |
1993年 | 1113篇 |
1992年 | 774篇 |
1991年 | 784篇 |
1990年 | 610篇 |
1989年 | 595篇 |
1988年 | 557篇 |
1987年 | 570篇 |
1986年 | 507篇 |
1985年 | 534篇 |
1984年 | 636篇 |
1983年 | 565篇 |
1982年 | 759篇 |
1981年 | 701篇 |
1980年 | 602篇 |
1979年 | 364篇 |
1978年 | 375篇 |
1977年 | 403篇 |
1976年 | 342篇 |
1975年 | 293篇 |
1974年 | 249篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
Thomas Heitz Peter Rohrbach Hartwig Hcker 《Macromolecular chemistry and physics.》1989,190(12):3295-3316
Liquid-crystalline main-chain polyesters with polystyrene side chains of different length and number per main chain were synthesized using aromatic hydroxyfunctional polystyrene (PS) macromonomers, terephthalic acid derivatives and tert-butylhydroquinone as co-diol. The molecular weight of the polystyrene side chain was varied in the range from 1000 to 20000. The influence of this novel type of substituent on the solubility, thermal behaviour and miscibility with PS as a flexible matrix polymer is discussed. The properties of the new compounds are compared to those of the respective homopolyester. The graft copolyesters are, depending on the characteristics of the polymeric substituent, soluble in common organic solvents and their thermal transition points are lowered compared to the homopolyester. Compared to blends of the homopolyester, the improvement of miscibility of the polymer-substituted rigid rods with PS as an example for a flexible matrix polymer can be valued as a step to molecular reinforcement. 相似文献
44.
45.
46.
Peter J. Morgan Lynda M. Williams Gary Davidson Wilfred Lawson Edward Howell 《Journal of neuroendocrinology》1989,1(1):1-4
The functional significance of the pars tuberalis (PT) of the mammalian adenohypophysis has remained an enigma (1, 2). One view of its function is that it acts as an auxiliary gland to support the endocrine role of the pars distalis (PD) (2), as it has been shown to contain immunocytochemically identifiable thyrotrophs and gonadotrophs (1). Many of the cells of the PT are, however, ultrastructurally unique suggesting an independent function for this tissue. Our recent demonstration that the PT of the rat is a major binding site for the ligand iodomelatonin lends further support to this idea (3). We have utilized the highly specific ligand [125 l]melatonin, and have demonstrated that it binds exclusively, with very high affinity, to the PT but not the PD of the adult sheep adenohypophysis. These findings support the conclusion that the PT has a distinct role in relation to melatonin action and seasonal reproduction. 相似文献
47.
TB in the elderly in industrialised countries. 总被引:1,自引:0,他引:1
Peter D O Davies 《The international journal of tuberculosis and lung disease》2007,11(11):1157-1159
48.
49.
Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation—Efficacy and Safety at Five Years 总被引:2,自引:0,他引:2
Christopher J. E. Watson J. Andrew Bradley Peter J. Friend John Firth Craig J. Taylor John R. Bradley Kenneth G. C. Smith Sathia Thiru Neville V. Jamieson Geoff Hale Herman Waldmann Roy Calne 《American journal of transplantation》2005,5(6):1347-1353
Alemtuzumab is a powerful lymphocyte depleting antibody currently being evaluated in solid organ transplantation. This paper describes 5-year results of a single center study of alemtuzumab as induction in renal transplantation. Thirty-three renal transplant recipients received 20 mg alemtuzumab on day 0 and 1, followed by half-dose cyclosporin monotherapy (trough concentration 75-125 ng/mL) from day 3. They were compared in a retrospective contemporaneous-controlled manner with 66 kidney transplant recipients transplanted in the same period and center who received conventional immunosuppression with cyclosporin, azathioprine and prednisolone. In the alemtuzumab group 12% of recipients died compared to 17% in the control group (p = 0.48); likewise graft loss was similar in both groups (21% vs. 26%, respectively, p = 0.58). Incidence of acute rejection was also comparable at 5 years (31.5% vs. 33.6%), although the pattern of rejection was different with 14% patients in the alemtuzumab group experiencing rejection over 1 year post-transplant compared to none in the control group. There was no significant difference between groups in terms of infection or serious adverse events. While acknowledging the limitations of a relatively small single-center study, results suggest that alemtuzumab induction allowed satisfactory long-term patient and graft survival equivalent to that seen with standard triple immunosuppression, while avoiding steroid therapy. 相似文献
50.